Suchergebnisse - "Hatherill, Mark"

PubPharm (48)

1

Conference report : WHO meeting summary on mRNA-based tuberculosis vaccine development

enthalten in: Vaccine | 2023

von Looney, M. | Hatherill, M. | Musvosvi, M. | +13

2

Clinical trials of tuberculosis vaccines in the era of increased access to preventive antibiotic treatment

enthalten in: The Lancet. Respiratory medicine | 2023

von Rangaka, M. | Frick, M. | Churchyard, G. | +9

3

Developing tuberculosis vaccines for people with HIV : consensus statements from an international expert panel

enthalten in: The lancet. HIV | 2022

von Miner, M. | Hatherill, M. | Mave, V. | +29

ErratumIn: Lancet HIV. 2022 Dec;9(12):e822. - PMID 36372080

4

End-point definition and trial design to advance tuberculosis vaccine development

enthalten in: European respiratory review : an official journal of the European Respiratory Society | 2022

von Garcia-Basteiro, A. | White, R. | Tait, D. | +16

5

Accelerating research and development of new vaccines against tuberculosis : a global roadmap

enthalten in: The Lancet. Infectious diseases | 2022

von Cobelens, F. | Suri, R. | Helinski, M. | +6

6

Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis : a randomised, double-blind, placebo-controlled, phase 2a trial

enthalten in: The Lancet. Respiratory medicine | 2021

von Day, T. | Penn-Nicholson, A. | Luabeya, A. | +65

ErratumIn: Lancet Respir Med. 2021 Jul;9(7):e62. - PMID 34214500

7

Multidimensional analyses reveal modulation of adaptive and innate immune subsets by tuberculosis vaccines

enthalten in: Communications biology | 2020

von Rozot, V. | Nemes, E. | Geldenhuys, H. | +118

8

A Trial of M72/AS01E Vaccine to Prevent Tuberculosis. Reply

enthalten in: The New England journal of medicine | 2020

von Tait, D. | Van Der Meeren, O. | Hatherill, M.

CommentOn: N Engl J Med. 2020 Apr 16;382(16):1576-1577. - PMID 32294368

9

Preferred product characteristics for therapeutic vaccines to improve tuberculosis treatment outcomes : Key considerations from World Health Organization consultations

enthalten in: Vaccine | 2020

von Vekemans, J. | Brennan, M. | Hatherill, M. | +8

10

Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis

enthalten in: The New England journal of medicine | 2019

von Tait, D. | Hatherill, M. | Van Der Meeren, O. | +24

CommentIn: Nature. 2020 Jan;577(7789):145. - PMID 31911698

1
2
3
4
5
Nächster »
[5]